ARCHIVES

FDA Rile Changes Reporting Requirements for Adverse Events

This article is from The Cancer Letter archive.

Vol. 20 No. 44 | November 18, 1994

Download PDF Visit The Full Archive

Related Articles

Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center

December 11, 1998

ASCO Objects To Proposed Graduate Medical Education Bill

September 20, 1985

MGMT Gene Can Determine Disease Aggressiveness

June 24, 2011

Scientists Lobby For Funding Increase. DuBois To Leave Vanderbilt For M.D. Anderson.

January 12, 2007

Smaller Ultrasound-Guided Biopsy Needle Safe, Effective, For Suspected Breast Cancer

May 30, 2003

In Brief: Kalt Named Director, NCI extramural Div.; Browning Is Deputy; Other DEA Staff Changes

June 10, 1994